|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 300 out of 657 for Ptf1a

Category restricted to Publication (x)

0.059s

Categories

Category: Publication
Type Details Score
Publication
First Author: Petrucco S
Year: 1990
Journal: Mol Cell Biol
Title: The DNA-binding activity of transcription factor PTF1 parallels the synthesis of pancreas-specific mRNAs during mouse development.
Volume: 10
Issue: 1
Pages: 254-64
Publication
First Author: Liu Y
Year: 2001
Journal: J Biol Chem
Title: DNA binding and transcriptional activation by a PDX1.PBX1b.MEIS2b trimer and cooperation with a pancreas-specific basic helix-loop-helix complex.
Volume: 276
Issue: 21
Pages: 17985-93
Publication
First Author: Adams EJ
Year: 2014
Journal: J Biol Chem
Title: Mammalian COPII coat component SEC24C is required for embryonic development in mice.
Volume: 289
Issue: 30
Pages: 20858-70
Publication
First Author: Khasawneh J
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion.
Volume: 106
Issue: 9
Pages: 3354-9
Publication
First Author: Bastea LI
Year: 2019
Journal: Cancer Res
Title: Pomalidomide Alters Pancreatic Macrophage Populations to Generate an Immune-Responsive Environment at Precancerous and Cancerous Lesions.
Volume: 79
Issue: 7
Pages: 1535-1548
Publication
First Author: Frank KJ
Year: 2022
Journal: Cell Rep Med
Title: Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer.
Volume: 3
Issue: 11
Pages: 100815
Publication
First Author: Tourlakis ME
Year: 2015
Journal: PLoS Genet
Title: In Vivo Senescence in the Sbds-Deficient Murine Pancreas: Cell-Type Specific Consequences of Translation Insufficiency.
Volume: 11
Issue: 6
Pages: e1005288
Publication
First Author: Collins MA
Year: 2012
Journal: J Clin Invest
Title: Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice.
Volume: 122
Issue: 2
Pages: 639-53
Publication  
First Author: Döppler H
Year: 2016
Journal: Sci Rep
Title: The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer.
Volume: 6
Pages: 33758
Publication
First Author: Singh SK
Year: 2015
Journal: EMBO J
Title: Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity.
Volume: 34
Issue: 4
Pages: 517-30
Publication
First Author: Flowers BM
Year: 2021
Journal: Cancer Discov
Title: Cell of Origin Influences Pancreatic Cancer Subtype.
Volume: 11
Issue: 3
Pages: 660-677
Publication
First Author: Benitz S
Year: 2016
Journal: Oncotarget
Title: Polycomb repressor complex 1 promotes gene silencing through H2AK119 mono-ubiquitination in acinar-to-ductal metaplasia and pancreatic cancer cells.
Volume: 7
Issue: 10
Pages: 11424-33
Publication
First Author: Neuß T
Year: 2024
Journal: Cancer Res
Title: Metabolic Reprogramming Is an Initial Step in Pancreatic Carcinogenesis That Can Be Targeted to Inhibit Acinar-to-Ductal Metaplasia.
Volume: 84
Issue: 14
Pages: 2297-2312
Publication
First Author: Kurz E
Year: 2022
Journal: Cancer Cell
Title: Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer.
Volume: 40
Issue: 7
Pages: 720-737.e5
Publication
First Author: Andricovich J
Year: 2018
Journal: Cancer Cell
Title: Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors.
Volume: 33
Issue: 3
Pages: 512-526.e8
Publication
First Author: Seidler B
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: A Cre-loxP-based mouse model for conditional somatic gene expression and knockdown in vivo by using avian retroviral vectors.
Volume: 105
Issue: 29
Pages: 10137-42
Publication
First Author: Ying H
Year: 2012
Journal: Cell
Title: Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism.
Volume: 149
Issue: 3
Pages: 656-70
Publication
First Author: Conti AC
Year: 2009
Journal: Neurobiol Dis
Title: Adenylyl cyclases types 1 and 8 promote pro-survival pathways after ethanol exposure in the neonatal brain.
Volume: 33
Issue: 1
Pages: 111-8
Publication
First Author: Shi C
Year: 2014
Journal: Lab Invest
Title: Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage-stellate cell interaction.
Volume: 94
Issue: 4
Pages: 409-21
Publication
First Author: Mende M
Year: 2016
Journal: Neuron
Title: Sensory-Derived Glutamate Regulates Presynaptic Inhibitory Terminals in Mouse Spinal Cord.
Volume: 90
Issue: 6
Pages: 1189-1202
Publication
First Author: Heiser PW
Year: 2008
Journal: Gastroenterology
Title: Stabilization of beta-catenin induces pancreas tumor formation.
Volume: 135
Issue: 4
Pages: 1288-300
Publication
First Author: Morris JP 4th
Year: 2010
Journal: J Clin Invest
Title: Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice.
Volume: 120
Issue: 2
Pages: 508-20
Publication
First Author: Miyatsuka T
Year: 2006
Journal: Genes Dev
Title: Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation.
Volume: 20
Issue: 11
Pages: 1435-40
Publication
First Author: Criscimanna A
Year: 2011
Journal: Gastroenterology
Title: Duct cells contribute to regeneration of endocrine and acinar cells following pancreatic damage in adult mice.
Volume: 141
Issue: 4
Pages: 1451-62, 1462.e1-6
Publication
First Author: Aguilera KY
Year: 2014
Journal: Cancer Res
Title: Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma.
Volume: 74
Issue: 4
Pages: 1032-44
Publication
First Author: Kidger AM
Year: 2022
Journal: Oncogene
Title: Suppression of mutant Kirsten-RAS (KRASG12D)-driven pancreatic carcinogenesis by dual-specificity MAP kinase phosphatases 5 and 6.
Volume: 41
Issue: 20
Pages: 2811-2823
Publication
First Author: Alam A
Year: 2022
Journal: Cancer Cell
Title: Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer.
Volume: 40
Issue: 2
Pages: 153-167.e11
Publication
First Author: Jiang H
Year: 2016
Journal: Nat Med
Title: Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.
Volume: 22
Issue: 8
Pages: 851-60
Publication
First Author: Somani VK
Year: 2022
Journal: Gastroenterology
Title: IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma.
Volume: 162
Issue: 7
Pages: 2047-2062
Publication
First Author: Assouline B
Year: 2024
Journal: Nat Commun
Title: Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8(+) T cell activation and limit responsiveness to immunotherapy in mice.
Volume: 15
Issue: 1
Pages: 6162
Publication  
First Author: Taylor AJ
Year: 2023
Journal: Mol Metab
Title: Islet amyloid polypeptide does not suppress pancreatic cancer.
Volume: 68
Pages: 101667
Publication
First Author: Cheung PF
Year: 2022
Journal: Nat Commun
Title: Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression.
Volume: 13
Issue: 1
Pages: 156
Publication
First Author: Schug C
Year: 2019
Journal: Mol Cancer Res
Title: A Novel Approach for Image-Guided 131I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene Delivery.
Volume: 17
Issue: 1
Pages: 310-320
Publication
First Author: Bermejo-Rodriguez C
Year: 2024
Journal: Cancer Res
Title: Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis.
Volume: 84
Issue: 18
Pages: 2968-2984
Publication
First Author: Morris JP 4th
Year: 2019
Journal: Nature
Title: α-Ketoglutarate links p53 to cell fate during tumour suppression.
Volume: 573
Issue: 7775
Pages: 595-599
Publication
First Author: Reynoird N
Year: 2016
Journal: Genes Dev
Title: Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer.
Volume: 30
Issue: 7
Pages: 772-85
Publication
First Author: Fujimoto TN
Year: 2019
Journal: Cancer Res
Title: Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer.
Volume: 79
Issue: 9
Pages: 2327-2338
Publication  
First Author: Masuda T
Year: 2023
Journal: J Clin Invest
Title: Pancreatic RECK inactivation promotes cancer formation, epithelial-mesenchymal transition, and metastasis.
Volume: 133
Issue: 18
Publication
First Author: Rajurkar M
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis.
Volume: 109
Issue: 17
Pages: E1038-47
Publication
First Author: Dey P
Year: 2020
Journal: Cancer Discov
Title: Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment.
Volume: 10
Issue: 4
Pages: 608-625
Publication
First Author: Guccini I
Year: 2023
Journal: iScience
Title: Genetic ablation of ketohexokinase C isoform impairs pancreatic cancer development.
Volume: 26
Issue: 8
Pages: 107368
Publication
First Author: Hou P
Year: 2021
Journal: Genes Dev
Title: USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer.
Volume: 35
Issue: 19-20
Pages: 1327-1332
Publication
First Author: Morton JP
Year: 2008
Journal: Am J Pathol
Title: Trp53 deletion stimulates the formation of metastatic pancreatic tumors.
Volume: 172
Issue: 4
Pages: 1081-7
Publication
First Author: Jameson KL
Year: 2013
Journal: Nat Med
Title: IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase-driven tumors.
Volume: 19
Issue: 5
Pages: 626-630
Publication
First Author: Shankar S
Year: 2020
Journal: Nat Commun
Title: An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development.
Volume: 11
Issue: 1
Pages: 2817
Publication
First Author: Razidlo GL
Year: 2015
Journal: Cancer Res
Title: Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion.
Volume: 75
Issue: 14
Pages: 2907-15
Publication
First Author: Olson P
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: Imaging guided trials of the angiogenesis inhibitor sunitinib in mouse models predict efficacy in pancreatic neuroendocrine but not ductal carcinoma.
Volume: 108
Issue: 49
Pages: E1275-84
Publication
First Author: Yao W
Year: 2019
Journal: Nature
Title: Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer.
Volume: 568
Issue: 7752
Pages: 410-414
Publication
First Author: Mills LD
Year: 2014
Journal: J Biol Chem
Title: Inactivation of the transcription factor GLI1 accelerates pancreatic cancer progression.
Volume: 289
Issue: 23
Pages: 16516-25
Publication
First Author: He B
Year: 2024
Journal: Cell Death Dis
Title: Epigenetic priming targets tumor heterogeneity to shift transcriptomic phenotype of pancreatic ductal adenocarcinoma towards a Vitamin D susceptible state.
Volume: 15
Issue: 1
Pages: 89
Publication
First Author: Steiner S
Year: 2022
Journal: Oncogene
Title: De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancer.
Volume: 41
Issue: 10
Pages: 1507-1517
Publication
First Author: Hezel AF
Year: 2012
Journal: Cancer Res
Title: TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progression.
Volume: 72
Issue: 18
Pages: 4840-5
Publication  
First Author: Hidalgo-Sastre A
Year: 2020
Journal: JCI Insight
Title: Loss of Wasl improves pancreatic cancer outcome.
Volume: 5
Issue: 10
Publication
First Author: Martinelli P
Year: 2016
Journal: Gut
Title: The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice.
Volume: 65
Issue: 3
Pages: 476-86
Publication
First Author: Li L
Year: 2013
Journal: Cell
Title: Hijacking the neuronal NMDAR signaling circuit to promote tumor growth and invasion.
Volume: 153
Issue: 1
Pages: 86-100
Publication
First Author: Terekhanova NV
Year: 2023
Journal: Nature
Title: Epigenetic regulation during cancer transitions across 11 tumour types.
Volume: 623
Issue: 7986
Pages: 432-441
Publication
First Author: Siveke JT
Year: 2008
Journal: Gastroenterology
Title: Notch signaling is required for exocrine regeneration after acute pancreatitis.
Volume: 134
Issue: 2
Pages: 544-55
Publication
First Author: Zhang Y
Year: 2013
Journal: Cancer Res
Title: Canonical wnt signaling is required for pancreatic carcinogenesis.
Volume: 73
Issue: 15
Pages: 4909-22
Publication
First Author: Cobo I
Year: 2018
Journal: Nature
Title: Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas.
Volume: 554
Issue: 7693
Pages: 533-537
Publication
First Author: Murakami S
Year: 2017
Journal: Oncogene
Title: Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma.
Volume: 36
Issue: 9
Pages: 1232-1244
Publication
First Author: Puri S
Year: 2013
Journal: PLoS One
Title: Elimination of von Hippel-Lindau function perturbs pancreas endocrine homeostasis in mice.
Volume: 8
Issue: 8
Pages: e72213
Publication
First Author: Satoh D
Year: 2016
Journal: Neuron
Title: Context-Dependent Gait Choice Elicited by EphA4 Mutation in Lbx1 Spinal Interneurons.
Volume: 89
Issue: 5
Pages: 1046-58
Publication
First Author: Hidalgo-Sastre A
Year: 2016
Journal: Am J Pathol
Title: Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model.
Volume: 186
Issue: 11
Pages: 2934-2944
Publication
First Author: Kopp JL
Year: 2018
Journal: Gastroenterology
Title: Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
Volume: 154
Issue: 5
Pages: 1509-1523.e5
Publication
First Author: Telley L
Year: 2016
Journal: Neuron
Title: Dual Function of NRP1 in Axon Guidance and Subcellular Target Recognition in Cerebellum.
Volume: 91
Issue: 6
Pages: 1276-1291
Publication
First Author: Fauquier T
Year: 2014
Journal: Development
Title: Purkinje cells and Bergmann glia are primary targets of the TRα1 thyroid hormone receptor during mouse cerebellum postnatal development.
Volume: 141
Issue: 1
Pages: 166-75
Publication  
First Author: Jahncke JN
Year: 2024
Journal: eNeuro
Title: Tools for Cre-Mediated Conditional Deletion of Floxed Alleles from Developing Cerebellar Purkinje Cells.
Volume: 11
Issue: 6
Publication
First Author: Gams A
Year: 2023
Journal: Physiol Rep
Title: Evidence of sex differences in cancer-related cardiac complications in mouse models of pancreatic and liver cancer.
Volume: 11
Issue: 8
Pages: e15672
Publication
First Author: Hedegger K
Year: 2020
Journal: J Gastroenterol
Title: The protective effect of betacellulin against acute pancreatitis is ERBB4 dependent.
Volume: 55
Issue: 3
Pages: 317-329
Publication
First Author: Collins MA
Year: 2012
Journal: PLoS One
Title: Metastatic pancreatic cancer is dependent on oncogenic Kras in mice.
Volume: 7
Issue: 12
Pages: e49707
Publication
First Author: Zierke L
Year: 2024
Journal: Cell Mol Life Sci
Title: Initiation of acute pancreatitis in mice is independent of fusion between lysosomes and zymogen granules.
Volume: 81
Issue: 1
Pages: 207
Publication
First Author: Fuerst PG
Year: 2012
Journal: Dev Biol
Title: Cell autonomy of DSCAM function in retinal development.
Volume: 361
Issue: 2
Pages: 326-37
Publication
First Author: Shi G
Year: 2009
Journal: Gastroenterology
Title: Loss of the acinar-restricted transcription factor Mist1 accelerates Kras-induced pancreatic intraepithelial neoplasia.
Volume: 136
Issue: 4
Pages: 1368-78
Publication
First Author: Chen L
Year: 2019
Journal: Nat Commun
Title: Interleukin 22 disrupts pancreatic function in newborn mice expressing IL-23.
Volume: 10
Issue: 1
Pages: 4517
Publication
First Author: Xiao X
Year: 2013
Journal: Diabetes
Title: TGFβ receptor signaling is essential for inflammation-induced but not β-cell workload-induced β-cell proliferation.
Volume: 62
Issue: 4
Pages: 1217-26
Publication
First Author: Sato T
Year: 2017
Journal: Cancer Sci
Title: c-Jun N-terminal kinase in pancreatic tumor stroma augments tumor development in mice.
Volume: 108
Issue: 11
Pages: 2156-2165
Publication
First Author: Zhang AMY
Year: 2023
Journal: Cell Metab
Title: Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation.
Volume: 35
Issue: 12
Pages: 2119-2135.e5
Publication
First Author: Kalisz M
Year: 2020
Journal: EMBO J
Title: HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer.
Volume: 39
Issue: 9
Pages: e102808
Publication
First Author: Miyabayashi K
Year: 2013
Journal: Cancer Res
Title: Erlotinib prolongs survival in pancreatic cancer by blocking gemcitabine-induced MAPK signals.
Volume: 73
Issue: 7
Pages: 2221-34
Publication  
First Author: Kishikawa T
Year: 2016
Journal: Nat Commun
Title: Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1.
Volume: 7
Pages: 13006
Publication
First Author: Ijichi H
Year: 2011
Journal: J Clin Invest
Title: Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma.
Volume: 121
Issue: 10
Pages: 4106-17
Publication
First Author: Özdemir BC
Year: 2014
Journal: Cancer Cell
Title: Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.
Volume: 25
Issue: 6
Pages: 719-34
Publication
First Author: Dosch AR
Year: 2020
Journal: Mol Cancer Res
Title: Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic Cancer.
Volume: 18
Issue: 4
Pages: 623-631
Publication
First Author: Takahashi R
Year: 2020
Journal: Sci Rep
Title: Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer.
Volume: 10
Issue: 1
Pages: 21194
Publication
First Author: Kopp JL
Year: 2012
Journal: Cancer Cell
Title: Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma.
Volume: 22
Issue: 6
Pages: 737-50
Publication
First Author: DeNicola GM
Year: 2011
Journal: Nature
Title: Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.
Volume: 475
Issue: 7354
Pages: 106-9
Publication
First Author: Izeradjene K
Year: 2007
Journal: Cancer Cell
Title: Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.
Volume: 11
Issue: 3
Pages: 229-43
Publication
First Author: Grüner BM
Year: 2012
Journal: PLoS One
Title: MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer.
Volume: 7
Issue: 6
Pages: e39424
Publication
First Author: Zambirinis CP
Year: 2015
Journal: J Exp Med
Title: TLR9 ligation in pancreatic stellate cells promotes tumorigenesis.
Volume: 212
Issue: 12
Pages: 2077-94
Publication
First Author: Rielland M
Year: 2014
Journal: J Clin Invest
Title: Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression.
Volume: 124
Issue: 5
Pages: 2125-35
Publication
First Author: Zolghadri Y
Year: 2018
Journal: Am J Pathol
Title: Malnutrition in Pancreatic Ductal Adenocarcinoma (PDA): Dietary Pancreatic Enzymes Improve Short-Term Health but Stimulate Tumor Growth.
Volume: 188
Issue: 3
Pages: 616-626
Publication
First Author: Drosos Y
Year: 2017
Journal: Sci Rep
Title: ATM-deficiency increases genomic instability and metastatic potential in a mouse model of pancreatic cancer.
Volume: 7
Issue: 1
Pages: 11144
Publication
First Author: Sehrawat A
Year: 2020
Journal: J Biol Chem
Title: SMAD7 enhances adult β-cell proliferation without significantly affecting β-cell function in mice.
Volume: 295
Issue: 15
Pages: 4858-4869
Publication
First Author: Ocal O
Year: 2015
Journal: Dis Model Mech
Title: A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics.
Volume: 8
Issue: 10
Pages: 1201-11
Publication
First Author: DelGiorno KE
Year: 2020
Journal: Gastroenterology
Title: Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D2.
Volume: 159
Issue: 5
Pages: 1866-1881.e8
Publication
First Author: Layeghi-Ghalehsoukhteh S
Year: 2020
Journal: Sci Rep
Title: Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics.
Volume: 10
Issue: 1
Pages: 20662
Publication
First Author: Zhao Y
Year: 2020
Journal: Cancer Res
Title: Oncogene-Induced Senescence Limits the Progression of Pancreatic Neoplasia through Production of Activin A.
Volume: 80
Issue: 16
Pages: 3359-3371
Publication
First Author: Zhou R
Year: 2016
Journal: Oncogene
Title: A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
Volume: 35
Issue: 43
Pages: 5608-5618
Publication
First Author: Takahashi K
Year: 2017
Journal: Sci Rep
Title: Disruption of Small GTPase Rab7 Exacerbates the Severity of Acute Pancreatitis in Experimental Mouse Models.
Volume: 7
Issue: 1
Pages: 2817
Publication
First Author: Principe DR
Year: 2016
Journal: Cancer Res
Title: TGFβ Signaling in the Pancreatic Tumor Microenvironment Promotes Fibrosis and Immune Evasion to Facilitate Tumorigenesis.
Volume: 76
Issue: 9
Pages: 2525-39